Clearpoint Neuro (CLPT) closed at $9.25 on October 21, 2026, down 2.1% from the previous close, on volume of 391,394 shares (30-day average 692,062).
Data as of October 21, 2026.
PRNewswire (Thu, 15-Oct 10:02 AM ET)
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
ACCESS Newswire (Wed, 14-Oct 4:05 PM ET)
Business Wire (Wed, 7-Oct 10:12 PM ET)
ClearPoint Neuro Faces Investor Alert After Partner Reports No Statistical Significance at 48 Months
Market Chameleon (Wed, 7-Oct 7:59 AM ET)
ClearPoint Neuro Sets Stage for Growth with Focused Ultrasound Expansion and Regulatory Tailwinds
Market Chameleon (Tue, 4-Aug 3:06 AM ET)
ClearPoint Neuro Reports Second Quarter 2026 Results
ACCESS Newswire (Mon, 3-Aug 4:05 PM ET)
ACCESS Newswire (Fri, 31-Jul 4:05 PM ET)
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
ACCESS Newswire (Tue, 21-Jul 4:05 PM ET)
ClearPoint Neuro Targets Brain Drug Delivery Leap With 10-Year Ultrasound Partnership
Market Chameleon (Thu, 18-Jun 3:30 AM ET)
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Clearpoint Neuro trades on the NASDAQ stock market under the symbol CLPT.
As of October 21, 2026, CLPT stock price declined to $9.25 with 391,394 million shares trading.
CLPT has a beta of 2.89, meaning it tends to be more sensitive to market movements. CLPT has a correlation of 0.17 to the broad based SPY ETF.
CLPT has a market cap of $277.40 million. This is considered a Small Cap stock.
Last quarter Clearpoint Neuro reported $11 million in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.10.
In the last 3 years, CLPT traded as high as $30.10 and as low as $4.05.
The top ETF exchange traded funds that CLPT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
CLPT has underperformed the market in the last year with a price return of -66.1% while the SPY ETF gained +16.3%. CLPT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.5% and -16.0%, respectively, while the SPY returned +4.4% and -0.8%, respectively.
CLPT support price is $8.99 and resistance is $9.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLPT shares will trade within this expected range on the day.